Cancer Treatment Centers of America

John Conway Named CTCA Chief Business Development Officer

Commitment to growth and expansion to be focus of new position

(Schaumburg, Ill. March 25, 2013) Cancer Treatment Centers of America® (CTCA) is pleased to announce that John Conway, Sr. Vice President of Business Development and Market Access, has been promoted to Chief Business Development Officer. In his new role, Conway will assume senior responsibility for the Business Development function and for leading the relationships between CTCA and payors, employers and government organizations, reporting directly to Stephen Bonner, President and Chief Executive Officer.

Conway has over 25 years of experience in the insurance industry and has been with CTCA for the past five and a half years. According to Conway, his focus will be to “continue the growth and expansion of our system to support the ever increasing demand for our very personal, customized and integrated cancer treatment services.”

Conway’s promotion was announced on March 21, 2013 with Bonner saying that Conway “assembled a wonderful and growing team to bring CTCA credibility, differentiation and creativity in relationships that can make it easier for our patients to access CTCA services.”

Continuing his advancement of business relationships, Conway will “communicate the differentiated value of CTCA to strategic audiences such as health plans, and health plan purchasers, with the singular goal of increasing and supporting access to CTCA for the patients that seek our care”

About Cancer Treatment Centers of America®
Cancer Treatment Centers of America Global, Inc. (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-informed supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Reflecting our patient-centered approach to cancer care, our patient satisfaction scores consistently rank among the highest in the country for cancer care providers, and CTCA is also rated one of the most admired hospital systems in the country in national consumer surveys. For more information, visit, and